What’s the relationship between high blood pressure and Lupus Nephritis? Some patients who have been diagnosed with Lupus Nephritis also have high blood pressure at the same time. Indeed, Lupus Nephritis ( Berger’s disease) can really suffer from high blood pressure. Lupus Nephropathy is a kind of kidney disease and long time damage in kidney can really lead to increased blood pressure.
Berger’s disease is a kind of renal glomerular nephritis. About 23% to 70% patients with chronic renal glomerular nephritis will suffer from high blood pressure with the disease developing. The more renal function declines, the higher blood pressure will be. In addition, lesion in renal parenchyma and renal tubules can also lead to high blood pressure such as insufficiency of chronic pyelonephritis. Half of them can lead to high blood pressure.
Once diagnosed accompanied by high blood pressure, patients with Lupus Nephritis should apply medicines which can lower blood pressure besides plasma exchange, and other medicine such as monoclonal antibody, and so on. As for medicine which can lower blood pressure, Chinese Medicine is a priority.
Firstly, Chinese Medicine can extend all levels of arteries, improve the micro-blood circulation, increase the effective perfusion in the kidney, relieve the insufficiency of blood and oxygen, increase the metabolism in partial area, which can also accelerate the repair of renal intrinsic cells such as renal arterial endothelial cells, thus relieving high blood pressure.
Secondly, Chinese Medicine can also inhibit the release of inflammatory mediators and inactivate the materials which can lead to damage to the kidney, thus reducing the further damage to the renal intrinsic cells, stopping the development of renal fibrosis and treating high blood pressure fundamentally.
At present, the theory in our Hospital is becoming more and more systematic. At present, Chinese Medicine has becomes part of immunotherapy which is on the basis of the theory that most kidney diseases are caused by immune disorder.
No comments:
Post a Comment